š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The overall aim of this project is to evaluate the immunogenicity of TIV va...
Status
Completed
Location
Nrf/Dst Vpd Rmpru
Start Date
2013-05
Trial ID
NCT01812980
Treatments Being Tested
This is a Phase Ib study in healthy adults (18-70 years) to evaluate the sa...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2012-08
Trial ID
NCT01676402
Treatments Being Tested
Influenza (flu) viruses change continuously, therefore also the parts of vi...
Status
Completed
Location
Site Reference ID/Investigator# 59243
Start Date
2009-06
Trial ID
NCT00881842
Treatments Being Tested
This prospective annual release study was designed to assess the safety of ...
Status
Completed
Location
Research Site
Start Date
2012-05
Trial ID
NCT01579916
Treatments Being Tested
The hypothesis proposed in this study is that the 2011-2012 Seasonal Influe...
Status
Unknown
Location
National Institute of Public Health
Start Date
2012-04
Trial ID
NCT01577316
Treatments Being Tested
This is an exploratory study using a strategy that has not been previously ...
Status
Completed
Location
Stanford LPCH Vaccine Program
Start Date
2009-07
Trial ID
NCT02133781
Treatments Being Tested
The purpose of this study is to generate additional data on the immunogenic...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT01011049
This study is designed to test the safety and immunogenicity of FluviralĀ® (...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-07-11
Trial ID
NCT00929331
Treatments Being Tested
Each potential subject will be screened before the start of the study to de...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01356316
Treatments Being Tested
The purpose of the present study is to assess the immunogenicity, safety an...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09-12
Trial ID
NCT00968890
Treatments Being Tested